Contribution for new genetic markers of rheumatoid arthritis activity and severity: Sequencing of the tumor necrosis factor-alpha gene promoter

Arthritis Research and Therapy

Volumn 9, Issue , 2007, Pages

  Fonseca, João Eurico ^a,b   Cavaleiro, João ^a   Teles, José ^a   Sousa, Elsa ^a,b   Andreozzi, Valeska L ^c   Antunes, Marília ^d   Amaral Turkman, Maria Antonia ^d   Canhão, Helena ^a,b   Mourão, Ana Filipa ^a,e   Lopes, Joana ^a   Caetano Lopes, Joana ^a   Weinmann, Pamela ^a   Sobral, Marta ^a   Nero, Patrícia ^e   Saavedra, Maria J ^f   Malcata, Armando ^f   Cruz, Margarida ^g   Melo, Rui ^h   Braña, Araceli ⁱ   Miranda, Luis ^j   Patto, José V ^j   Barcelos, Anabela ^k   da Silva, José Canas ^l   Santos, Luís M ^m   Figueiredo, Guilherme ^m   Rodrigues, Mário ⁿ   Jesus, Herberto ⁿ   Quintal, Alberto ⁿ   Carvalho, Teresa ^a   da Silva, José A Pereira ^b   Branco, Jaime ^e   Queiroz, Mário Viana ^b   more..

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Center of Statistics Applications of Lisbon University CEAUL   (Portugal)

^e HOSPITAL EGAS MONIZ   (Portugal)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^g Faro Hospital   (Portugal)

^h Hospital Nossa Senhora da Assuncaõ   (Portugal)

ⁱ Caldas da Rainha Hospital   (Portugal)

^j INSTITUTO PORTUGUÊS DE REUMATOLOGIA   (Portugal)

^k Hospital Infante D Pedro EPE   (Portugal)

^l HOSPITAL GARCIA DE ORTA   (Portugal)

^m HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

ⁿ HOSPITAL CENTRAL DO FUNCHAL   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT DEGENERATION; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROMOTER REGION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; WORK DISABILITY; DISABILITY; GENETICS; JOINT; MEDICAL LEAVE; MIDDLE AGED; ONSET AGE; ORTHOPEDIC SURGERY; PATHOLOGY;

AGE OF ONSET; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; JOINTS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SICK LEAVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247855059     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2173     Document Type: Article

References (32)

1. Maini RN Taylor PC Paleolog E Charles P Ballara S Brennan FM Feldmann M Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis Ann Rheum Dis 1999 58 Suppl 1 I56-60 1766574 10577974
2. Van der Linden MW Huizinga TW Stoeken DJ Sturk A Westendorp RG Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: Assessment of laboratory error and individual variation J Immunol Methods 1998 218 63-71 10.1016/ S0022-1759(98)00108-2 9819123
3. Westendorp RG Langermans JA Huizinga TW Verweij CL Sturk A Genetic influence on cytokine production in meningococcal disease Lancet 1997 349 1912-1913 10.1016/S0140-6736(05)63910-4 9217780
4. Bayley JP Ottenhoff TH Verweij CL Is there a future for TNF promoter polymorphisms? Genes Immun 2004 5 315-329 10.1038/sj.gene.6364055 14973548
5. Verweij CL Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis Ann Rheum Dis 1999 58 Suppl 1 I20-I26 1766583 10577969
6. de Vries N Tak PP The response to anti-TNF-alpha treatment: Gene regulation at the bedside Rheumatology (Oxford) 2005 44 705-707 10.1093/ rheumatology/keh662 15855186
7. Fonseca JE Carvalho T Cruz M Nero P Sobral M Mourão AF Cavaleiro J Ligeiro D Abreu I Carmo-Fonseca M Branco JC Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics Ann Rheum Dis 2005 64 793-794 10.1136/ard.2004.028167 15834068
8. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988 31 315-324 10.1002/art.1780310302 3358796
9. Fonseca JE Canhão H Reis P Jesus H Pereira da Silva JA Viana Queiroz M [Rheumatoid arthritis clinical protocol] Jornal CIAR 2001 11 113-118
10. van der Heijde D How to read radiographs according to the SvdH/van der Heijde method J Rheumatol 2000 27 261-263 10648051
11. Fries JF Spitz P Kraines RG Holman HR Measurement of patient outcome in arthritis Arthritis Rheum 1980 23 137-145 10.1002/art.1780230202 7362664
12. Prevoo ML van't Hof MA Kuper HH van Leeuwen MA van de Pute LB Van Riel PL Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 1995 38 44-48 10.1002/art.1780380107 7818570
13. Antunes M Andreozzi V Amaral Turkman MA A Note on the Use of Bayesian Hierarchical Models for Supervised Classification. CEAUL Research Report 13/2006 Lisbon: Faculdade de Ciências da Universidade de Lisboa Press 2006
14. Barrett JC Fry B Maller J Daly MJ Haploview: Analysis and visualization of LD and haplotype maps Bioinformatics 2005 21 263-265 10.1093/ bioinformatics/bth457 15297300
15. The R project for statistical computing http://www.r-project.org/
16. Fonseca JE Canhão H Dias FC Leandro MJ Resende C Teixeira da Costa JC Pereira da Silva JA Viana Queiroz M Severity of rheumatoid arthritis in Portuguese patients: Comment on the article by Drosos et al and on the letter by Ronda et al Arthritis Rheum 2000 43 470-472 10.1002/ 1529-0131(200002)43:2<470::AID-ANR36>3.0.CO;2-D 10693895
17. Cvetkovic JT Wallberg-Jonsson S Stegmayr B Rantapaa-Dahlqvist S Lefvert AK Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1 beta, and IL-1 Ra genes J Rheumatol 2002 29 212-219 11838837
18. Maury CP Liljeström M Laiho K Tiitinen S Kaarela K Hurme M Tumor necrosis factor α, its soluble receptor I and -308 gene promoter polymorphism in patient with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenis of nephropathy and anemia of chronic disease in reactive amyloidosis Arthritis Rheum 2003 48 3068-3076 10.1002/art.11294 14613268
19. Braun N Michel U Ernst BP Metzner R Bitsch A Weber F Rieckmann P Gene polymorphisms at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production Neurosci Lett 1996 215 75-78 8887999
20. Wu WS McClain KL DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH) J Interferon Cytokine Res 1997 17 631-635 9355965
21. Kroeger KM Carville KS Abraham L The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription Mol Immunol 1997 34 391-399 10.1016/S0161-5890(97)00052-7 9293772
22. Uglialoro AM Turbay D Pesavento PA Delgado JC McKenzie FE Gribben JG Hartl D Yunis EJ Goldfeld AE Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter Tissue Antigens 1998 52 359-367 9820599
23. Brinkman BM Zuijdeest D Kaijzel EL Breedveld FC Verweij CL Relevance of the tumor necrosis factor α (TNFα) -308 promoter polymorphism in TNF α gene regulation J Inflamm 1995 46 32-41 8832970
24. Baseggio L Bartholin L Chantome A Charlot C Rimokh R Salles G Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter Eur J Immunogenet 2004 31 15-19 10.1111/j.1365-2370.2004.00440.x 15009176
25. Kang CP Lee KW Yoo DH Kang C Bae SC The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis Rheumatology (Oxford) 2005 44 547-552 10.1093/rheumatology/keh550 15695296
26. van Heel DA Udalova IA De Silva AP McGovern DP Kinouchi Y Hull J Lench NJ Cardon LR Carey AH Jewell DP Kwiatkowski D Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors Hum Mol Genet 2002 11 1281-1289 10.1093/hmg/11.11.1281 12019209
27. Skoog T van't Hooft F Kallin B Jovinge S Boquist S Nilsson J Eriksson P Hamsten A A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α Hum Mol Genet 1999 8 1443-1449 10.1093/hmg/ 8.8.1443 10400991
28. Huizinga TW Westendorp RG Bollen EL Keijsers V Brinkman BM Langermans JA Breedveld FC Verweij CL van de Gaer L Dams L TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients J Neuroimmunol 1997 72 149-153 10.1016/ S0165-5728(96)00182-8 9042107
29. Pociot F D'Alfonso A Compasso S Scorza R Richiardi PM Functional analysis of a new polymorphism in the human TNF alpha gene promoter Scand J Immunol 1995 42 501-504 10.1111/j.1365-3083.1995.tb03686.x 7569785
30. Hajeer AH Hutchinson IV Influence of TNFα gene polymorphisms on TNFα production and disease Hum Immunol 2001 62 1191-1199 10.1016/ S0198-8859(01)00322-6 11704281
31. Fabris M Di PE D'Elia A Damante G Sinigaglia L Ferraccioli G Tumor necrosis factor-α gene polymorphism in severe and mild-moderate rheumatoid arthritis J Rheumatol 2002 29 29-33 11824966
32. Brinkman BM Huizinga TW Kurban SS van der Velde EA Schreuder GM Hazes JM Breedveld FC Verweij CL Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease? Br J Rheumatol 1997 36 516-521 10.1093/rheumatology/ 36.5.516 9189051